HUP0001262A3 - 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one deriatives, their preparation and their use as dopamine autoreceptor (d2) agonists - Google Patents

4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one deriatives, their preparation and their use as dopamine autoreceptor (d2) agonists

Info

Publication number
HUP0001262A3
HUP0001262A3 HU0001262A HUP0001262A HUP0001262A3 HU P0001262 A3 HUP0001262 A3 HU P0001262A3 HU 0001262 A HU0001262 A HU 0001262A HU P0001262 A HUP0001262 A HU P0001262A HU P0001262 A3 HUP0001262 A3 HU P0001262A3
Authority
HU
Hungary
Prior art keywords
deriatives
dihydrobenzoimidazol
aminoalkoxy
agonists
preparation
Prior art date
Application number
HU0001262A
Other languages
English (en)
Hungarian (hu)
Original Assignee
American Home Products Corp Ma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp Ma filed Critical American Home Products Corp Ma
Publication of HUP0001262A2 publication Critical patent/HUP0001262A2/hu
Publication of HUP0001262A3 publication Critical patent/HUP0001262A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU0001262A 1997-02-18 1998-01-13 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one deriatives, their preparation and their use as dopamine autoreceptor (d2) agonists HUP0001262A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80187097A 1997-02-18 1997-02-18
PCT/US1998/000623 WO1998035946A1 (en) 1997-02-18 1998-01-13 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists

Publications (2)

Publication Number Publication Date
HUP0001262A2 HUP0001262A2 (hu) 2001-04-28
HUP0001262A3 true HUP0001262A3 (en) 2002-04-29

Family

ID=25182225

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0001262A HUP0001262A3 (en) 1997-02-18 1998-01-13 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one deriatives, their preparation and their use as dopamine autoreceptor (d2) agonists

Country Status (14)

Country Link
EP (1) EP0964853A1 (pt)
JP (1) JP2001511804A (pt)
KR (1) KR20000071160A (pt)
CN (1) CN1138761C (pt)
AR (1) AR011138A1 (pt)
AU (1) AU744443B2 (pt)
BR (1) BR9807703A (pt)
CA (1) CA2278747A1 (pt)
HU (1) HUP0001262A3 (pt)
IL (1) IL131156A0 (pt)
NZ (1) NZ337271A (pt)
TW (1) TW383303B (pt)
WO (1) WO1998035946A1 (pt)
ZA (1) ZA981310B (pt)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE914003A1 (en) * 1990-11-20 1992-05-20 Astra Pharma Prod Biologically Active Amines
GB9210632D0 (en) * 1992-05-19 1992-07-01 Fisons Plc Compounds
ATE210657T1 (de) * 1994-10-14 2001-12-15 Merck Patent Gmbh Zns wirksames (r)-(-)-2-(5-(4-fluorophenyl)-3- pyridylmethylaminomethyl)chroman
AR004523A1 (es) * 1995-11-06 1998-12-16 American Home Prod 2-(AMINOMETIL)-3,4,7,9-TETRAHIDRO-2H-PIRANO-[2,3e] INDOL-8-ONAS Y COMPOSICIONES FARMACEUTICAS QUE LAS COMPRENDEN
CA2264072A1 (en) * 1996-08-27 1998-03-05 American Home Products Corporation 4-aminoethoxy-indolone derivatives as dopamine d2 agonists
JP2000516959A (ja) * 1996-08-27 2000-12-19 アメリカン・ホーム・プロダクツ・コーポレイション 4―アミノエトキシインドロン誘導体

Also Published As

Publication number Publication date
EP0964853A1 (en) 1999-12-22
IL131156A0 (en) 2001-01-28
BR9807703A (pt) 2000-05-02
CA2278747A1 (en) 1998-08-20
CN1252060A (zh) 2000-05-03
TW383303B (en) 2000-03-01
CN1138761C (zh) 2004-02-18
HUP0001262A2 (hu) 2001-04-28
NZ337271A (en) 2001-01-26
ZA981310B (en) 1999-08-17
JP2001511804A (ja) 2001-08-14
AU6023498A (en) 1998-09-08
WO1998035946A1 (en) 1998-08-20
AU744443B2 (en) 2002-02-21
AR011138A1 (es) 2000-08-02
KR20000071160A (ko) 2000-11-25

Similar Documents

Publication Publication Date Title
SG87776A1 (en) Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals
AU6325599A (en) New compounds, their preparation and use
AU6325899A (en) New compounds, their preparation and use
AU6190199A (en) New compounds, their preparation and use
AU6325799A (en) New compounds, their preparation and use
HK1078561A1 (en) Novel compounds, their use and preparation
AU6190299A (en) New compounds, their preparation and use
PL351312A1 (en) New compounds, their preparation and use
AU6325699A (en) New compounds, their preparation and use
HUP0103884A3 (en) Arylsulfonanilide urea-derivatives, pharmaceutical compositions containing them and their use
PL351250A1 (en) Antipicornaviral compounds, their preparation and use
GB9712317D0 (en) Composition, compound and use
GB9817235D0 (en) Compound,composition and use
HK1031725A1 (en) 3-amino-3-arylpropan-1-ol-derivates, their preparation and their use
AU3595099A (en) New compounds, their preparation and use
GB9817236D0 (en) Compound,composition and use
GB9718876D0 (en) Compound,composition and use
GB9903447D0 (en) Compound, composition and use
GB9817238D0 (en) Compound,composition and use
GB9917593D0 (en) Compound, composition, process and use
IL131158A0 (en) 4-Aminoalkoxy-1h-benzimidazole derivatives their preparation and their use as dopamine autoreceptor (d2) agonists
GB9723859D0 (en) Compound,composition and use
HUP0001262A3 (en) 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one deriatives, their preparation and their use as dopamine autoreceptor (d2) agonists
HK1028595A1 (en) Substituted cycloheptenes, their preparation and use
SI1043306T1 (en) 3-amino-3-arylpropan-1-ol-derivates, their preparation and use